1. WayeJ. Small bowel endoscopy. Endoscopy1999;31:56. CrossRef

2. OatesB, MorrisA. Enteroscopy. Curr Opin Gastroenterol2000;16:121. CrossRef

3. RhodesA, ShorvonP. Recent advances in small‐bowel imaging: a review. Curr Opin Gastroenterol2001;17:132. CrossRef

4. YamamotoH, SekineY, SatoY, et al.Total enteroscopy with a nonsurgical steerable double‐balloon method. Gastrointest Endosc2001;53:216. CrossRef

5. JonnalagaddaS. Double balloon enteroscopy: wired technology meets wireless. Gastroenterology2006;131:327. CrossRef

6. EisenGM. Small‐bowel endoscopy. Gastrointest Endosc2012;76:521. CrossRef

7. RastogiA, SchoenRE, SlivkaA. Diagnostic yield and clinical outcomes of capsule endoscopy. Gastrointest Endosc2004;60:959. CrossRef

8. EnnsR, GoK, ChangH, et al.Capsule endoscopy: a single‐centre experience with the first 226 capsules. Can J Gastroenterol2004;18:555.

9. MaieronA, HubnerD, BlahaB, et al.Multicenter retrospective evaluation of capsule endoscopy in clinical routine. Endoscopy2004;36:864. CrossRef

10. MataA, BordasJM, FeuF, et al.Wireless capsule endoscopy in patients with obscure gastrointestinal bleeding: a comparative study with push enteroscopy. Aliment Pharmacol Ther2004;20:189. CrossRef

11. GeZZ, HuYB, XiaoSD. Capsule endoscopy in diagnosis of small bowel Crohn's disease. World J Gastroenterol2004;10:1349.

12. HaraAK, LeightonJA, SharmaVK, et al.Small bowel: preliminary comparison of capsule endoscopy with barium study and CT. Radiology2004;230:260. CrossRef

13. LiangpunsakulS, ChadalawadaV, RexDK, et al.Wireless capsule endoscopy detects small bowel ulcers in patients with normal results from state of the art enteroclysis. Am J Gastroenterol2003;98:1295. CrossRef

14. MarmoR, RotondanoG, PiscopoR, et al.Meta‐analysis: capsule enteroscopy vs. conventional modalities in diagnosis of small bowel diseases. Aliment Pharmacol Ther2005;22:595. CrossRef

15. ErsoyO, HarmanciO, AydinliM, et al.Capability of capsule endoscopy in detecting small bowel ulcers. Dig Dis Sci2009;54:136. CrossRef

16. DohertyGA, MossAC, CheifetzAS. Capsule endoscopy for small‐bowel evaluation in Crohn's disease. Gastrointest Endosc2011;74:167. CrossRef

17. EliakimR. Video capsule endoscopy of the small bowel. Curr Opin Gastroenterol2013;29:133. CrossRef

18. BaltesP, SteinbruckI, BrandtL, et al.Inflammatory lesions in the small bowel. Video J Enc GI Endosc2013;1:241.

19. MonkemullerK, Safatle‐RibeiroA, OlanoC, et al.Unusual findings in the small bowel. Video J Enc GI Endosc2013;1:286.

20. IddanG, MeronG, GlukhovskyA, et al.Wireless capsule endoscopy. Nature2000;405:417. CrossRef

21. AppleyardM, FiremanZ, GlukhovskyA, et al.A randomized trial comparing wireless capsule endoscopy with push enteroscopy for the detection of small‐bowel lesions. Gastroenterology2000;119:1431. CrossRef

22. AppleyardM, GlukhovskyA, SwainP. Wireless‐capsule diagnostic endoscopy for recurrent small‐bowel bleeding. N Engl J Med2001;344:232. CrossRef

23. ChenX, RanZH, TongJL. A meta‐analysis of the yield of capsule endoscopy compared to double‐balloon enteroscopy in patients with small bowel diseases. World J Gastroenterol2007;13:4372. CrossRef

24. YamamotoH. Double‐balloon endoscopy. Clin Gastroenterol Hepatol2005;3(7 Suppl 1):S27. CrossRef

25. YamamotoH, KitaH. Double‐balloon endoscopy. Curr Opin Gastroenterol2005;21:573. CrossRef

26. EllC, MayA, NachbarL, et al.Push‐and‐pull enteroscopy in the small bowel using the double‐balloon technique: results of a prospective European multicenter study. Endoscopy2005;37:613. CrossRef

27. NakamuraM, NiwaY, OhmiyaN, et al.Preliminary comparison of capsule endoscopy and double‐balloon enteroscopy in patients with suspected small‐bowel bleeding. Endoscopy2006;38:59. CrossRef

28. HadithiM, HeineGD, JacobsMA, et al.A prospective study comparing video capsule endoscopy with double‐balloon enteroscopy in patients with obscure gastrointestinal bleeding. Am J Gastroenterol2006;101:52. CrossRef

29. KhashabMA, LennonAM, DunbarKB, et al.A comparative evaluation of single‐balloon enteroscopy and spiral enteroscopy for patients with mid‐gut disorders. Gastrointest Endosc2010;72:766. CrossRef

30. MayA, NachbarL, EllC. Double‐balloon enteroscopy (push‐and‐pull enteroscopy) of the small bowel: feasibility and diagnostic and therapeutic yield in patients with suspected small bowel disease. Gastrointest Endosc2005;62:62. CrossRef

31. MayA, NachbarL, PohlJ, et al.Endoscopic interventions in the small bowel using double balloon enteroscopy: feasibility and limitations. Am J Gastroenterol2007;102:527. CrossRef

32. TsujikawaT, SaitohY, AndohA, et al.Novel single‐balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy2008;40:11. CrossRef

33. HeineGD, HadithiM, GroenenMJ, et al.Double‐balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small‐bowel disease. Endoscopy2006;38:42. CrossRef

34. MonkemullerK, WeigtJ, TreiberG, et al.Diagnostic and therapeutic impact of double‐balloon enteroscopy. Endoscopy2006;38:67. CrossRef

35. Costa‐SilvaL, BrandãoAC. MR enterography for the assessment of small bowel diseases. Magn Reson Imaging Clin N Am2013;21:365. CrossRef

36. LauW, FanS, ChuK, et al.Intra‐operative fibreoptic enteroscopy for bleeding lesions in the small intestine. Br J Surg1986;73:217. CrossRef

37. DelmotteJ, GayG, HouckeP, et al.Intraoperative endoscopy. Gastrointest Endosc Clin N Am1999;9:61.

38. IngrossoM, PreteF, PisaniA, et al.Laparoscopically assisted total enteroscopy: a new approach to small intestinal diseases. Gastrointest Endosc1999;49:651. CrossRef

39. GrandDJ, HarrisA, LoftusEV. Imaging for luminal disease and complications: CT enterography, MR enterography, small‐bowel follow‐through, and ultrasound. Gastroenterol Clin North Am2012;41:497. CrossRef

40. BriziMG, MinordiLM, MirkP, et al.The state of the art of small bowel imaging: combine the old with the new. Rays2002;27:51.

41. SailerJ, PeloschekP, SchoberE, et al.Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's disease. AJR Am J Roentgenol2005;185:1575. CrossRef

42. LiuYB, LiangCH, ZhangZL, et al.Crohn disease of the small bowel: multidetector row CT with CT enteroclysis, dynamic contrast enhancement, CT angiography, and 3D imaging. Abdom Imaging2006;31:668. CrossRef

43. SchmidtS, FelleyC, MeuwlyJY, et al.CT enteroclysis: technique and clinical applications. Eur Radiol2006;16:648. CrossRef

44. GilesE, BarclayAR, ChippingtonS, et al.Systematic review: MRI enterography for assessment of small bowel involvement in paediatric Crohn's disease. Aliment Pharmacol Ther2013;37:1121. CrossRef

45. Al‐HawaryMM, ZimmermannEM, HussainHK. MR imaging of the small bowel in Crohn disease. Magn Reson Imaging Clin N Am2014;22:13. CrossRef

46. MasselliG, BriziMG, MenchiniL, et al.Magnetic Resonance Enteroclysis imaging of Crohn's. Radiol Med2005;110:221.

47. WiardaBM, KuipersEJ, HoudijkLP, et al.MR enteroclysis: imaging technique of choice in diagnosis of small bowel diseases. Dig Dis Sci2005;50:1036. CrossRef

48. GourtsoyiannisN, PapanikolaouN, GrammatikakisJ, et al.Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol2004;14:1017. CrossRef

49. BaerA, BaylessT, YardleyJ. Intestinal ulceration and malabsorption syndromes. Gastroenterology1980;79:754.

50. BoydstunJ, GaffeyT, BartholomewL. Clinicopathologic study of nonspecific ulcers of the small intestine. Dig Dis Sci1981;26:911. CrossRef

51. DaviesD, BrightmoreT. Idiopathic and drug‐induced ulceration of the small intestine. Br J Surg1970;57:134. CrossRef

52. ReidJ, GilmourH, HoltS. Primary non‐specific ulcer of the small intestine. J R Coll Surg Edinb1982;27:228.

53. GlynnM, PendowerJ, ShoushaS, et al.Recurrent bleeding from idiopathic ulceration of small bowel. BMJ1984;288:975. CrossRef

54. ThomasW, WilliamsonR. Nonspecific small bowel ulceration. Postgrad Med1985;61:587. CrossRef

55. BallantyneK, MorrisD, HawkeyC, et al.Haemorrhage from idiopathic annular ulcers of the small intestine. Ann R Coll Surg Engl1986;68:168.

56. MatsumotoT, IidaM, MatsuiT, et al.Chronic nonspecific multiple ulcers of the small intestine: a proposal of the entity from Japanese gastroenterologists to Western enteroscopists. Gastrointest Endosc2007;66(3 Suppl):S99. CrossRef

57. MatsumotoT, KubokuraN, MatsuiT, et al.Chronic nonspecific multiple ulcer of the small intestine segregates in offspring from consanguinity. J Crohns Colitis2011;5:559. CrossRef

58. MatsumotoT, IidaM, MatsuiT, et al.Non‐specific multiple ulcers of the small intestine unrelated to non‐steroidal anti‐inflammatory drugs. J Clin Pathol2004;57:1145. CrossRef

59. MatsumotoT, NakamuraS, EsakiM, et al.Endoscopic features of chronic nonspecific multiple ulcers of the small intestine: comparison with nonsteroidal anti‐inflammatory drug‐induced enteropathy. Dig Dis Sci2006;51:1357. CrossRef

60. GuestJ. Nonspecific ulceration of the intestine. Int Abstr Surg1963;117:409.

61. MorgensternL, FrelichM, PanishJ. The circumferential small bowel ulcer: clinical aspects in 17 patients. JAMA1965;191:637. CrossRef

62. KakegawaS, KojimaM, OhwadaS, et al.Idiopathic ulcer of the small bowel containing numerous plasma cells: case resembling mucosa‐associated lymphoid tissue lymphoma. J Gastroenterol Hepatol2005;20:1304. CrossRef

63. AthieC, GuizarC, AlcantaraA, et al.Twenty‐five years of experience in the surgical treatment of perforation of the ileum caused by Salmonella typhi at the General Hospital of Mexico City, Mexico. Surgery1998;123:632. CrossRef

64. StonerM, ForsytheR, MillsA, et al.Intestinal perforation secondary to Salmonella typhi: case report and review of the literature. Am Surg2000;66:219.

65. JonnalagaddaS, PrakashC. Intestinal strictures can impede wireless capsule enteroscopy. Gastrointest Endosc2003;57:418. CrossRef

66. AnnibaleB, CapursoG, BacciniF, et al.Role of small bowel investigation in iron deficiency anaemia after negative endoscopic/histologic evaluation of the upper and lower gastrointestinal tract. Dig Liver Dis2003;35:784. CrossRef

67. CapursoG, LahnerE, PallottaN, et al.Iron deficiency anemia caused by nonspecific (idiopathic) small bowel ulceration: an uncommon presentation of an uncommon disease. Can J Gastroenterol2002;16:855.

68. RajuGS, GersonL, DasA, et al.American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology2007;133:1697. CrossRef

69. BonnetS, DouardR, MalamutG, et al.Intraoperative enteroscopy in the management of obscure gastrointestinal bleeding. Dig Liver Dis2013;45:277. CrossRef

70. IatropoulosM, DavisT. Ulcerative and inflammatory lesions. In: RozmanK, HanninenO(eds). Gastrointestinal Toxicology. Amsterdam: Elsevier; 1986: 267.

71. BiscariniL. Anti‐inflammatory analgesics and drugs used in gout. In: DukesMNG, AronsonJK(eds). Meyler's Side Effects of Drugs: an Encyclopedia of Adverse Reactions and Interactions, 14th edn. Amsterdam: Elsevier; 2000: 207.

72. FriesJ, MillerS, SpitzP, et al.Toward an epidemiology of gastropathy associated with non‐steroidal anti‐inflammatory drug use. Gastroenterology1989;96:647.

73. LangmanM. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology1989;96:640.

74. AabakkenL. Non‐steroidal anti‐inflammatory drugs: the extending scope of gastrointestinal side effects. Aliment Pharmacol Ther1992;6:143. CrossRef

75. GabrielS, BombardierC. NSAID induced ulcers: an emerging epidemic. J Rheumatol1990;17:1.

76. BjarnasonI, ZanelliG, SmithT, et al.Non‐steroidal anti‐inflammatory drug‐induced intestinal inflammation in humans. Gastroenterology1987;93:480.

77. WolfeM, LichtensteinD, SinghG. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med1999;340:1888. CrossRef

78. TenenbaumJ. The epidemiology of nonsteroidal anti‐inflammatory drugs. Can J Gastroenterol1999;13:119.

79. RahmeE, JosephL, KongS, et al.Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum2000;43:917. CrossRef

80. Alberto Garcia RodriguezL, Hernandez‐DiazS. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti‐inflammatory drugs. Epidemiology2001;12:570. CrossRef

81. JonssonB, HaglundU. Economic burden of NSAID‐induced gastropathy in Sweden. Scand J Gastroenterol2001;36:775. CrossRef

82. RahmeE, JosephL, KongS, et al.Cost of prescribed NSAID‐related gastrointestinal adverse events in elderly patients. Br J Clin Pharmacol2001;52:185. CrossRef

83. LangJ, PriceA, LeviA, et al.Diaphragm disease: pathology of disease of the small intestine induced by non‐steroidal anti‐inflammatory drugs. J Clin Pathol1988;41:516. CrossRef

84. LangmanM, MorganL, WorrallA. Use of anti‐inflammatory drugs by patients admitted with small or large bowel perforations and hemorrhage. BMJ1985;290:347. CrossRef

85. BjarnasonI, PriceA, ZanelliG, et al.Clinicopathological features of non‐steroidal anti‐inflammatory drug‐induced small intestinal strictures. Gastroenterology1988;94:1070.

86. SchneiderA, BenzC, RiemannJ. Adverse effects of nonsteroidal anti‐inflammatory drugs on the small and large bowel. Endoscopy1999;31:761. CrossRef

87. DaviesN, SalehJ, SkjodtN. Detection and prevention of NSAID‐induced enteropathy. J Pharm Sci2000;3:137.

88. HayashiY, YamamotoH, KitaH, et al.Non‐steroidal anti‐inflammatory drug‐induced small bowel injuries identified by double‐balloon endoscopy. World J Gastroenterol2005;11:4861. CrossRef

89. LengelingRW, MitrosFA, BrennanJA, et al.Ulcerative ileitis encountered at ileo‐colonoscopy: likely role of nonsteroidal agents. Clin Gastroenterol Hepatol2003;1:160. CrossRef

90. GoldsteinJL, EisenGM, LewisB, et al.Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol2005;3:133. CrossRef

91. ChanFK, LanasA, ScheimanJ, et al.Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet2010;376:173. CrossRef

92. BjarnasonI, WilliamsP, SuA, et al.Intestinal permeability and inflammation in rheumatic arthritis: effects of non‐steroidal anti‐inflammatory drugs. Lancet1984;2:1171. CrossRef

93. BjarnasonI, WilliamsP, SmethurstP, et al.Effect of non‐steroidal anti‐inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut1986;27:1292. CrossRef

94. RooneyP, JenkinsR, SmithK, et al.111Indium‐labeled polymorphonuclear leukocyte scans in rheumatoid arthritis: an important clinical cause of false positive results. Br J Rheumatol1986;25:167. CrossRef

95. SigthorssonG, TibbleJ, HayllarJ, et al.Intestinal permeability and inflammation in patients on NSAIDs. Gut1998;43:506. CrossRef

96. TibbleJ, SigthorrsonG, FosterR, et al.High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut1999;45:362. CrossRef

97. GrahamDY, OpekunAR, WillinghamFF, et al.Visible small‐intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol2005;3:55. CrossRef

98. MaidenL. Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug‐induced enteropathy. J Gastroenterol2009;44(Suppl 19):64. CrossRef

99. MaidenL, ThjodleifssonB, SeigalA, et al.Long‐term effects of nonsteroidal anti‐inflammatory drugs and cyclooxygenase‐2 selective agents on the small bowel: a cross‐sectional capsule enteroscopy study. Clin Gastroenterol Hepatol2007;5:1040. CrossRef

100. MaidenL, ThjodleifssonB, TheodorsA, et al.A quantitative analysis of NSAID‐induced small bowel pathology by capsule enteroscopy. Gastroenterology2005;128:1172. CrossRef

101. AllisonM, HowatsonA, TorranceC, et al.Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med1992;327:749. CrossRef

102. MorrisA, MadhokR, SturrockR, et al.Enteroscopic diagnosis of small bowel ulceration in patients receiving non‐steroidal anti‐inflammatory drugs. Lancet1991;337:520. CrossRef

103. GabrielS, JaakkimainenL, BombardierC. Risk for serious gastrointestinal complications related to use of nonsteroidal anti‐inflammatory drugs: a meta‐analysis. Ann Intern Med1991;115:787. CrossRef

104. WallaceJL. Polypharmacy of osteoarthritis: the perfect intestinal storm. Dig Dis Sci2013;58:3088. CrossRef

105. EndoH, SakaiE, HigurashiT, et al.Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy. Dig Liver Dis2012;44:833. CrossRef

106. WallaceJL. Mechanisms, prevention and clinical implications of nonsteroidal anti‐inflammatory drug‐enteropathy. World J Gastroenterol2013;19:1861. CrossRef

107. WatanabeT, TanigawaT, NadataniY, et al.Risk factors for severe nonsteroidal anti‐inflammatory drug‐induced small intestinal damage. Dig Liver Dis2013;45:390. CrossRef

108. SakaiE, EndoH, TaniguchiL, et al.Factors predicting the presence of small bowel lesions in patients with obscure gastrointestinal bleeding. Dig Endosc2013;25:412. CrossRef

109. WallaceJL, SyerS, DenouE, et al.Proton pump inhibitors exacerbate NSAID‐induced small intestinal injury by inducing dysbiosis. Gastroenterology2011;141:1314. CrossRef

110. JenkinsR, RooneyP, JonesD, et al.Increased intestinal permeability in patients with rheumatoid arthritis: a side‐effect of oral non‐steroidal anti‐inflammatory drug therapy?Br J Rheumatol1987;26:103. CrossRef

111. BjarnasonI, ZanelliG, ProuseP, et al.Effect of non‐steroidal anti‐inflammatory drugs on the human small intestine. Drugs1986;32(Suppl 1):35. CrossRef

112. BanerjeeA, PetersT. Experimental non‐steroidal anti‐inflammatory drug induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors. Gut1990;31:1358. CrossRef

113. HiguchiK, UmegakiE, WatanabeT, et al.Present status and strategy of NSAIDs‐induced small bowel injury. J Gastroenterol2009;44:879. CrossRef

114. WallaceJ. Nonsteroidal anti‐inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology1997;112:1000. CrossRef

115. KwoP, TremaineW. Nonsteroidal anti‐inflammatory drug‐induced enteropathy: case discussion and review of the literature. Mayo Clin Proc1995;70:55. CrossRef

116. BjarnasonI, HayllarJ, MacphersonA, et al.Side effects of nonsteroidal anti‐inflammatory drugs on the small and large intestine in humans. Gastroenterology1993;104:1832.

117. WhittleB. Temporal relationship between cyclooxygenase inhibition as measured by prostacyclin biosynthesis and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology1981;80:94.

118. LangenbachR, MorhamS, TianoH, et al.Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid‐induced inflammation and indomethacin‐induced gastric ulceration. Cell1995;83:483. CrossRef

119. WallaceJ, ReuterB, CicalaC, et al.Novel nonsteroidal anti‐inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology1994;107:173.

120. WallaceJ, ReuterB, CicalaC, et al.A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol1994;257:249. CrossRef

121. ReuterB, CirinoG, WallaceJ. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci1994;55:PL1. CrossRef

122. WallaceJ, ReuterB, CirinoG. Nitric oxide‐releasing non‐steroidal anti‐inflammatory drugs: a novel approach for reducing gastrointestinal toxicity. J Gastroenterol Hepatol1994;9(Suppl):40. CrossRef

123. ReuterB, DaviesN, WallaceJ, et al.Nonsteroidal anti‐inflammatory drug enteropathy in rats: role of permeability. Gastroenterology1997;112:109. CrossRef

124. NygardG, AnthonyA, PiaseckiC, et al.Acute indomethacin‐induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology1994;106:567.

125. WhittleB, LaszloF, EvansS, et al.Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol1995;116:2286. CrossRef

126. BjarnasonI, FehillyB, SmethhurstP, et al.Importance of local versus systemic effects of non‐steroidal anti‐inflammatory drugs in increasing small intestinal permeability in man. Gut1991;32:275. CrossRef

127. DaviesG, RamptonD. The pro‐drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non‐steroidal anti‐inflammatory drugs. Aliment Pharmacol Ther1991;5:593. CrossRef

128. BjarnasonI, SmethurstP, MacphersonA, et al.Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology1992;102:1546.

129. EricksonR. NSAIDs and the small intestine: is there any cause for concern?Pract Gastroenterol1991;105:39.

130. LeviS, de LaceyG, PriceA, et al."Diaphragm‐like" strictures of the small bowel in patients treated with non‐steroidal anti‐inflammatory drugs. Br J Radiol1990;63:186. CrossRef

131. MatsuhashiN, YamadaA, HiraishiM, et al.Multiple strictures of the small intestine after long‐term nonsteroidal anti‐inflammatory drug therapy. Am J Gastroenterol1992;87:1183.

132. HershfieldN. Endoscopic demonstration of non‐steroidal anti‐inflammatory drug‐induced small intestinal strictures. Gastrointest Endosc1992;38:388. CrossRef

133. SantolariaS, CabezaliR, OrtegoJ, et al.Diaphragm disease of the small bowel: a case without apparent nonsteroidal antiinflammatory drug use. J Clin Gastroenterol2001;32:344. CrossRef

134. AchantaK, PetrosJ, CaveD, et al.Use of intraoperative enteroscopy to diagnose nonsteroidal anti‐inflammatory drug injury to the small intestine. Gastrointest Endosc1999;49:544. CrossRef

135. TannerA, RaghunatH. Colonic inflammation and NSAID administration. Digestion1988;41:116. CrossRef

136. EvansJM, McMahonAD, MurrayFE, et al.Non‐steroidal anti‐inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut1997;40:619. CrossRef

137. BonnerGF, FakhriA, VennamaneniSR. A long‐term cohort study of nonsteroidal anti‐inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm Bowel Dis2004;10:751. CrossRef

138. FelderJB, KorelitzBI, RajapakseR, et al.Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case‐control study. Am J Gastroenterol2000;95:1949. CrossRef

139. TakeuchiK, SmaleS, PremchandP, et al.Prevalence and mechanism of nonsteroidal anti‐inflammatory drug‐induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol2006;4:196. CrossRef

140. Del FaveroA. Anti‐inflammatory drugs used in rheumatoid arthritis and gout. In: DukesMNG, AronsonJK(eds). Side Effects of Drugs Annual 15: a Worldwide Yearly Survey of New Data and Trends. Amsterdam: Elsevier; 1991: 92. CrossRef

141. RamptonD, SladenG. Relapse of ulcerative proctocolitis during treatment with NSAID. Postgrad Med J1981;57:297. CrossRef

142. KaufmanH, TaubinH. Nonsteroidal anti‐inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med1987;107:513. CrossRef

143. GiardielloF, HansenF, LazenbyA, et al.Collagenous colitis in setting of nonsteroidal antiinflammatory drugs and antibiotics. Dig Dis Sci1990;35:257. CrossRef

144. BattM. Non‐coeliac flat jejunal mucosa. Gut1989;30:67. CrossRef

145. FreemanH. Sulindac‐associated small bowel lesion. J Clin Gastroenterol1986;8:569. CrossRef

146. CooperB, HolmesG, CookeW. Celiac disease and malignancy. Medicine (Baltimore)1980;59:249. CrossRef

147. BruneK, DietzelK, NuernbergB, et al.Recent insight into the mechanism of gastrointestinal tract ulceration. Scand J Rheumatol Suppl1987;65:135. CrossRef

148. BeckW, SchneiderH, DietzelK, et al.Gastrointestinal ulcerations induced by anti‐inflammatory drugs in rats. Arch Toxicol1990;64:210. CrossRef

149. SigthorssonG, CraneR, SimonT, et al.COX‐2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut2000;47:527. CrossRef

150. ShahA, ThjodleifssonB, MurrayF, et al.Selective inhibition of COX‐2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut2001;48:339. CrossRef

151. LaineL, CurtisSP, LangmanM, et al.Lower gastrointestinal events in a double‐blind trial of the cyclo‐oxygenase‐2 selective inhibitor etoricoxib and the traditional nonsteroidal anti‐inflammatory drug diclofenac. Gastroenterology2008;135:1517. CrossRef

152. SoehngenE, Godin‐OstroE, FielderF, et al.Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats. Arthritis Rheum1988;31:414. CrossRef

153. BruneK, NuernbergB, SzelenyiI, et al.The enterohepatic circulation of some anti‐inflammatory drugs may cause intestinal ulcerations. In: RainsfordK, VeloG(eds). Side‐effects of Anti‐inflammatory Drugs: Part 2. Studies in Major Organ Systems. Lancaster, UK: MTP Press; 1987: 29. CrossRef

154. RobertA, AsanoT. Resistance of germ free rats to indomethacin‐induced intestinal lesions. Prostaglandins1977;14:331.

155. KentT, CardeliR, StanlerF. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol1969;54:237.

156. BjarnasonI, HopkinsonN, ZanelliG, et al.Treatment of non‐steroidal anti‐inflammatory drug induced enteropathy. Gut1990;31:777. CrossRef

157. WaismanY, ZahaviI, MarcusH, et al.Sucralfate is protective against indomethacin‐induced intestinal ulceration in the rat. Digestion1988;41:78. CrossRef

158. HarelL, ZahaviI, MarcusH, et al.Pentagastrin protects the proximal small intestine against indomethacin‐induced ulcers in the rat. Digestion1987;38:156. CrossRef

159. WaismanY, MarcusH, LigumskiM, et al.Modulation by opiates of small intestinal prostaglandin E2 and 3′,5′ cyclic adenosine monophosphate levels and of indomethacin‐induced ulceration in the rat. Life Sci1991;48:2035. CrossRef

160. KiroA, ZahaviI, MarcusH, et al.L‐dopa is protective against indomethacin‐induced small intestinal ulceration in the rat: possible role of an alpha‐2‐adrenergic mechanism. Life Sci1992;51:1151. CrossRef

161. WhitingP, BurkeM, ThomsonA. Drug interactions with cyclosporine: implications from animal studies. Transplant Proc1986;11:56.

162. GrahamD, AgarwalN, RothS. Prevention of NSAID‐induced gastric ulcer with the synthetic prostaglandin misoprostol: a multicenter double‐blind placebo‐controlled trial. Lancet1988;2:1277. CrossRef

163. GrahamD. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology1989;96:675.

164. GrahamD, WhiteR, MorelandL, et al.Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs: Misoprostol Study Group. Ann Intern Med1993;119:257. CrossRef

165. SontagS, SchnellJ, MakE, et al.Enprostil heals NSAID induced gastric ulcers. Gastroenterology1990;98:A129.

166. JaszewskiR, GrahamD, StromattS. Treatment of nonsteroidal antiinflammatory drug‐induced gastric ulcers with misoprostol: a double‐blind multicenter study. Dig Dis Sci1992;37:1820. CrossRef

167. TabataK, OkabeS. Effects of 16,16‐dimethyl‐PEG2‐methyl ester on aspirin‐ and indomethacin‐induced gastric and intestinal lesions in mini pigs. Digestion1983;26:61. CrossRef

168. RomainN, DandrifosseG, ForgetP, et al.Effect of prostaglandin E2 on the small intestine of indomethacin‐treated rats. Life Sci1987;41:1199. CrossRef

169. RobertA. An intestinal disease produced experimentally by prostaglandin deficiency. Gastroenterology1975;69:1045.

170. BjarnasonI, ZanelliG, SmithT, et al.The pathogenesis and consequence of non‐steroidal anti‐inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol1987;64:55. CrossRef

171. LeijonmarckC, RafL. Ulceration of the small intestine due to slow‐release potassium chloride tablets. Acta Chir Scand1985;151:273.

172. GrahamD. Effectiveness and tolerance of solid vs liquid potassium replacement therapy. In: WheltonPK, WheltonA(eds). Potassium in Cardiovascular and Renal Medicine. New York: Marcel Dekker; 1987: 435.

173. VenhoV. Toxicants in the gastrointestinal tract.. In: RozmanK, HanninenO(eds). Gastrointestinal Toxicology. Amsterdam: Elsevier; 1986: 363.

174. SteinH, UrowitzM. Gold‐induced enterocolitis: case report and literature review. J Rheumatol1976;3:21.

175. TeodorescuV, BauerJ, LichtigerS, et al.Gold‐induced colitis: a case report and review of the literature. Mt Sinai J Med1993;60:238.

176. JacksonC, HaboubiN, WhorwellP, et al.Gold induced enterocolitis. Gut1986;27:452. CrossRef

177. DortaG, SchneggJ, SaragaE, et al.Treatment of gold‐induced enteritis with octreotide [Letter]. Lancet1993;342:179. CrossRef

178. RemineS, McIlrathD. Bowel perforation in steroid‐treated patients. Ann Surg1980;192:581. CrossRef

179. StentoftJ. The toxicity of cytarabine. Drug Saf1990;5:7. CrossRef

180. FerrerM, BradleyS, WheelerH, et al.Effect of digoxin in splanchnic circulation in ventricular failure. Circulation1965;32:524. CrossRef

181. Roy‐ChaudhuryP, MeiselsIS, FreedmanS, et al.Combined gastric and ileocecal toxicity (serpiginous ulcers) after oral kayexalate in sorbital therapy. Am J Kidney Dis1997;30:120. CrossRef

182. McGowanCE, SahaS, ChuG, et al.Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. South Med J2009;102:493. CrossRef

183. MolinariM, Al‐SaifF, RyanEA, et al.Sirolimus‐induced ulceration of the small bowel in islet transplant recipients: report of two cases. Am J Transplant2005;5:2799. CrossRef

184. OgawaH, KurodaT, InadaM, et al.Intestinal Behcet's disease associated with myelodysplastic syndrome with chromosomal trisomy 8–a report of two cases and a review of the literature. Hepatogastroenterology2001;48:416.

185. BabaS, MarutaM, AndoK, et al.Intestinal Behcet's disease: report of 5 cases. Dis Colon Rectum1976;19:428. CrossRef

186. SayekI, AranO, UzunaliamogluB, et al.Intestinal Behçet's disease: surgical experience in seven cases. Hepatogastroenterology1991;38:81.

187. KormanU, CantasdemirM, KurugogluS, et al.Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease. Abdom Imaging2003;28:308. CrossRef

188. TakadaY, FujitaY, IgarashiM, et al.Intestinal Behçet's disease: pathognomonic changes in intramucosal lymphoid tissues and effect of a "rest cure" on intestinal lesions. J Gastroenterol1997;32:598. CrossRef

189. FujitaH, KiriyamaM, KawamuraT, et al.Massive hemorrhage in a patient with intestinal Behcet's disease: report of a case. Surg Today2002;32:378. CrossRef

190. NgFH, CheungTC, ChowKC, et al.Repeated intestinal perforation caused by an incomplete form of Behcet's syndrome. J Gastroenterol Hepatol2001;16:935. CrossRef

191. WhiteheadR. The alimentary tract in systemic disease and miscellaneous lesions. In: WhiteheadR(ed). Gastrointestinal and Oesophageal Pathology. New York: Churchill Livingstone; 1989: 827.

192. PostemaP, den HaanP, van HagenP, et al.Treatment of colitis in Behçet's disease with thalidomide. Eur J Gastroenterol Hepatol1996;8:929.

193. HamuryudanV, MatC, SaipS, et al.Thalidomide in the treatment of the mucocutaneous lesions of Behçet's syndrome: a randomized double‐blinded placebo controlled trial. Ann Intern Med1998;128:443. CrossRef

194. MochizukiM. Immunotherapy for Behçet's disease. Int Rev Immunol1997;14:49. CrossRef

195. TravisSP, CzajkowskiM, McGovernDP, et al.Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut2001;49:725. CrossRef

196. KramMT, MayLD, GoodmanS, et al.Behcet's ileocolitis: successful treatment with tumor necrosis factor‐alpha antibody (infliximab) therapy: report of a case. Dis Colon Rectum2003;46:118. CrossRef

197. AlpsoyE, YilmazE, BasaranE. Interferon therapy for Behçet's disease. J Am Acad Dermatol1994;31:617. CrossRef

198. HamuryudanV, MoralF, YurdakulS, et al.Systemic interferon alpha 2b treatment in Behçet's syndrome. J Rheumatol1994;21:1098.

199. AzizlerliG, SaricaR, KoseA, et al.Interferon alpha‐2a in the treatment of Behçet's disease. Dermatology1996;192:239. CrossRef

200. O'DuffyJ, CalamiaK, CohenS, et al.Alpha interferon treatment of Behçet's disease. J Rheumatol1998;25:1938.

201. LeeJH, CheonJH, JeonSW, et al.Efficacy of infliximab in intestinal Behcet's disease: a Korean multicenter retrospective study. Inflamm Bowel Dis2013;19:1833.

202. KasharaY, TanakaS, NishinoM, et al.Intestinal involvement in Behçet's disease. Dis Colon Rectum1981;24:103. CrossRef

203. IidaM, KobayashiH, MatsumotoT, et al.Postoperative recurrence in patients with intestinal Behçet's disease. Dis Colon Rectum1994;37:16. CrossRef

204. SasamuraH, NakamotoH, RyuzakiM, et al.Repeated intestinal ulcerations in a patient with systemic lupus erythematosus and high serum antiphospholipid antibody levels. South Med J1991;84:515. CrossRef

205. ValenteR, HallS, O'DuffyJ, et al.Vasculitis and related disorders. In: KellyWN, HarrisEJr, RuddyS, et al. (eds). Textbook of Rheumatology. Philadelphia: WB Saunders; 1997: 1079.

206. SunkureddiPR, LuuN, XiaoSY, et al.Eosinophilic enteritis with systemic lupus erythematosus. South Med J2005;98:1049. CrossRef

207. JuJH, MinJK, JungCK, et al.Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol2009;5:273. CrossRef

208. LevineSM, HellmannDB, StoneJH. Gastrointestinal involvement in polyarteritis nodosa (1986–2000): presentation and outcomes in 24 patients. Am J Med2002;112:386. CrossRef

209. EllisR, SmithC, GoodladJ, et al.Mesenteric vasculitis associated with Sezary syndrome. Gut1996;39:334. CrossRef

210. Leirisalo‐RepoM, TurunenU, StenmanS, et al.High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum1994;37:23. CrossRef

211. CappellM, SeiboldJ. Mesenteric thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosus. Am J Gastroenterol1992;87:520.

212. CappellM, MikhailN, GujralN. Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. Dig Dis Sci1994;39:1359. CrossRef

213. PerlemuterG, ChaussadeS, SoubraneO, et al.Multifocal stenosing ulcerations of the small intestine revealing vasculitis associated with C2 deficiency. Gastroenterology1996;110:1628. CrossRef

214. PerlemuterG, GuillevinL, LegmanP, et al.Cryptogenetic multifocal ulcerous stenosing enteritis: an atypical type of vasculitis or a disease mimicking vasculitis. Gut2001;48:333. CrossRef

215. SpencerH, KitsantaP, RileyS. Cryptogenic multifocal ulcerous stenosing enteritis. J R Soc Med2004;97:538. CrossRef

216. FreemanHJ. Multifocal stenosing ulceration of the small intestine. World J Gastroenterol2009;15:4883. CrossRef

217. KwonSO, KimYS, KimSY, et al.A case of cryptogenic multifocal ulcerous stenosing enteritis: differential diagnosis from Crohn's disease. J Gastrointestin Liver Dis2012;21:309.

218. KohoutovaD, BartovaJ, TacheciI, et al.Cryptogenic multifocal ulcerous stenosing enteritis: a review of the literature. Gastroenterol Res Pract2013;2013:918031. CrossRef

219. De SchepperH, MackenE, Van MarckV, et al.Infliximab induces remission in cryptogenic multifocal ulcerous stenosing enteritis: first case. World J Gastroenterol2013;19:1661. CrossRef

220. BiagiF, LorenziniP, CorazzaG. Literature review on the clinical relationship between ulcerative jejunoileitis celiac disease and enteropathy‐associated T‐cell lymphoma. Scand J Gastroenterol2000;8:785. CrossRef

221. ShroffS, GanapathiKA. Enteropathy associated T‐cell lymphoma: a review of diagnostic findings and therapeutic strategies. Diagn Histopathol2014;20:151. CrossRef

222. O'MahonyS, HowdleP, LosowskyM. Review article: management of patients with non‐responsive coeliac disease. Aliment Pharmacol Ther1996;10:671. CrossRef

223. IsaacsonP, WrightD. Malignant histiocytosis of the intestine: its relationship to malabsorption and ulcerative jejunitis. Hum Pathol1978;9:661. CrossRef

224. IsaacsonP. Malignant histiocytosis of the intestine: the early histological lesion. Gut1980;21:381. CrossRef

225. MacDonaldT, SpencerJ. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med1988;167:1341. CrossRef

226. KlaevemanH, GebhardR, SessomsC, et al.In vitro studies of ulcerative ileojejunitis. Gastroenterology1975;68:572.

227. RobertsonD, DixonM, ScottB, et al.Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease. Gut1983;24:565. CrossRef

228. RuanE, KomorowskiR, HoganW, et al.Nongranulomatous chronic idiopathic enterocolitis: clinicopathologic profile and response to corticosteroids. Gastroenterology1996;111:629. CrossRef

229. SoergelK. Nongranulomatous chronic idiopathic enterocolitis: a primary histologically defined disease. Dig Dis Sci2000;45:2085. CrossRef

230. HarrisO, CookeW, ThompsonH, et al.Malignancy in adult coeliac disease and idiopathic steatorrhoea. Am J Med1967;42:899. CrossRef

231. AustadW, CornesJ, GoughK, et al.Steatorrhoea and malignant lymphoma. Am J Dig Dis1983;12:475. CrossRef

232. CooperB, HolmesG, CookeW. Lymphoma risk in coeliac disease of later life. Digestion1982;23:89. CrossRef

233. Haagen NielsenO, JacobsenO, Rask PedersenE, et al.Nontropical sprue: malignant diseases and mortality rate. Scand J Gastroenterol1985;20:13. CrossRef

234. LoganR, RifkindE, TurnerI, et al.Mortality in celiac disease. Gastroenterology1989;97:265.

235. IsaacsonP, SpencerJ, ConnollyC, et al.Malignant histiocytosis of the intestine: a T‐cell lymphoma. Lancet1985;2:688. CrossRef

236. SalterD, KrajewskiA, DewarA. Immunophenotype analysis of malignant histiocytosis of the intestine. J Clin Pathol1986;39:8. CrossRef

237. SpencerJ, Cerf‐BensussanN, JarryA, et al.Enteropathy‐associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML‐1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol1988;132:1. CrossRef

238. JeffriesG, SteinbergH, SleisengerM. Chronic ulcerative (nongranulomatous) jejunitis. Am J Med1968;44:47. CrossRef

239. MurrayA, CuevasE, JonesD, et al.Study of the immunohistochemistry and T cell clonality of enteropathy‐associated T cell lymphoma. Am J Pathol1995;146:509.

240. Ashton‐KeyM, DissT, PanL, et al.Molecular analysis of T‐cell clonality in ulcerative jejunitis and enteropathy‐associated T‐cell lymphoma. Am J Pathol1997;151:493.

241. BagdiE, DissT, MunsonP, et al.Mucosal intra‐epithelial lymphocytes in enteropathy‐associated T‐cell lymphoma, ulcerative jejunoileitis and refractory celiac disease constitute a neoplastic population. Blood1999;94:260.

242. MillsP, BrownI, WatkinsonG. Idiopathic chronic ulcerative enteritis. Q J Med1980;49:133.

243. ObermannEC, DissTC, HamoudiRA, et al.Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy‐type T‐cell lymphoma. J Pathol2004;202:252. CrossRef

244. GilinskyN, MeeA, BeattyD, et al.Plasma cell infiltration of the small bowel: lack of evidence for a non‐secretory form of alpha heavy chain disease. Gut1985;26:928. CrossRef

245. McDonaldG, SchufflerM, KadinM, et al.Intestinal pseudolymphoma caused by diffuse lymphoid infiltration of the small intestine. Gastroenterology1985;89:882.

246. SmithW, PriceS, IsaacsonP. Immunoglobulin gene rearrangement in immunoproliferative small intestinal disease (IPSID). J Clin Pathol1987;40:1291. CrossRef

247. MatuchanskyC, CogneM, LemaireM, et al.Nonsecretory alpha‐chain disease with immunoproliferative small‐intestinal disease. N Engl J Med1989;320:1534. CrossRef

248. RoehrkasseR, RobertsI, WaldA, et al.Celiac sprue complicated by lymphoma presenting with multiple gastric ulcers. Gastroenterology1986;91:740.

249. LoughranT, MarshallE, KadinE, et al.T‐cell lymphoma associated with celiac sprue. Ann Intern Med1986;104:44. CrossRef

250. FairleyN, MackieF. A clinical and biochemical syndrome in lymphadenoma and allied diseases involving the mesenteric lymph glands. BMJ1937;1:375. CrossRef

251. GoughK, ReadA, NaishJ. Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut1962;3:232. CrossRef

252. LamontC, AdamsF, MillsP. Radiology in idiopathic chronic ulcerative enteritis. Clin Radiol1982;33:283. CrossRef

253. BruntonF, GuyerP. Malignant histiocytosis and ulcerative jejunitis of the small intestine. Clin Radiol1983;34:291. CrossRef

254. FreemanM, ChoS‐R. Nongranulomatous ulcerative jejunoileitis. Am J Gastroenterol1984;79:446.

255. BrousseN, MeijerJW. Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol2005;19:401. CrossRef

256. MaurinoE, NiveloniS, ChernavskyA, et al.Azathioprine in refractory sprue: results from a prospective, open‐label study. Am J Gastroenterol2002;97:2595. CrossRef

257. HolmesG, PriorR, LaneM, et al.Malignancy in coeliac disease: effect of a gluten free diet. Gut1989;30:333. CrossRef

258. HolmesGK. Coeliac disease and malignancy. Dig Liver Dis2002;34:229. CrossRef

259. SwinsonC, ColesE, SlavinG, et al.Coeliac disease and malignancy. Lancet1983;1:111. CrossRef

260. GaleJ, SimmondsPD, MeadGM, et al.Enteropathy‐type intestinal T‐cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol2000;18:795.

261. BishtonMJ, HaynesAP. Combination chemotherapy followed by autologous stem cell transplant for enteropathy‐associated T cell lymphoma. Br J Haematol2007;136:111. CrossRef

262. JantunenE, BoumendilA, FinelH, et al.Autologous stem cell transplantation for enteropathy‐associated T‐cell lymphoma: a retrospective study by the EBMT. Blood2013;121:2529. CrossRef

263. Walker‐SmithJA, UnsworthDJ, HutchinsP, et al.Autoantibodies against gut epithelium in child with small‐intestinal enteropathy. Lancet1982;1:566.

264. UnsworthJ, HutchinsP, MitchellJ, et al.Flat small intestinal mucosa and autoantibodies against the gut epithelium. J Pediatr Gastroenterol Nutr1982;1:503. CrossRef

265. ElwingJE, ClouseRE. Adult‐onset autoimmune enteropathy in the setting of thymoma successfully treated with infliximab. Dig Dis Sci2005;50:928. CrossRef

266. CorazzaGR, BiagiF, VoltaU, et al.Autoimmune enteropathy and villous atrophy in adults. Lancet1997;350:106. CrossRef

267. UnsworthDJ, Walker‐SmithJA. Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr1985;4:375. CrossRef

268. LeonF, OlivenciaP, Rodriguez‐PenaR, et al.Clinical and immunological features of adult‐onset generalized autoimmune gut disorder. Am J Gastroenterol2004;99:1563. CrossRef

269. SandersonIR, PhillipsAD, SpencerJ, et al.Response to autoimmune enteropathy to cyclosporin A therapy. Gut1991;32:1421. CrossRef

270. RolnyP, SigurjonsdottirHA, RemottiH, et al.Role of immunosuppressive therapy in refractory sprue‐like disease. Am J Gastroenterol1999;94:219. CrossRef

271. DaumS, SahinE, JansenA, et al.Adult autoimmune enteropathy treated successfully with tacrolimus. Digestion2003;68:86. CrossRef

272. VanderhoofJA, YoungRJ. Autoimmune enteropathy in a child: response to infliximab therapy. J Pediatr Gastroenterol Nutr2002;34:312. CrossRef

273. LeeF. Drug‐related pathological lesions of the intestinal tract. Histopathology1994;25:303. CrossRef

274. GatenbyR. The radiology of drug‐induced disorders in the gastrointestinal tract. Semin Roentgenol1995;30:62. CrossRef

275. GoreRM, LevineMS, GhahremaniGG. Drug‐induced disorders of the stomach and duodenum. Abdom Imaging1999;24:9. CrossRef

276. NeitlichJD, BurrellMI. Drug‐induced disorders of the small bowel. Abdom Imaging1999;24:17. CrossRef

277. ParfittJR, DrimanDK. Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol2007;38:527. CrossRef

278. PusztaszeriMP, GentaRM, CryerBL. Drug‐induced injury in the gastrointestinal tract: clinical and pathologic considerations. Nat Clin Pract Gastroenterol Hepatol2007;4:442. CrossRef

279. YoungJ. Abdominal catastrophes. Emerg Med Clin North Am1989;7:699.

280. WilcoxM, HowardT, PlaskonL, et al.Current theories of pathogenesis and treatment of nonocclusive mesenteric ischemia. Dig Dis Sci1995;40:709. CrossRef

281. FederleM, ChunG, JeffreyR, et al.Computed tomography findings in bowel infarction. AJR Am J Roentgenol1984;142:91. CrossRef

282. ClavienP, HuberO, MirescyD, et al.Contrast enhances CT scan as a diagnostic procedure in mesenteric ischaemia due to mesenteric venous thrombosis. Br J Surg1989;76:93. CrossRef

283. LewisJ. Gastrointestinal injury due to medicinal agents. Am J Gastroenterol1986;81:819.

284. SachsS, MortonJ, SchwartzS. Acute mesenteric ischemia. Surgery1982;92:646.

285. BowermanR, SteinmetzE, SchwartenD, et al.Reversal of digitalis‐induced mesenteric vasospasm by sodium nitroprusside. Arch Intern Med1982;142:403. CrossRef

286. GoglinW, ElliottB, DeppeS. Nifedipine‐induced hypotension and mesenteric ischemia. South Med J1989;82:274. CrossRef

287. MuellerP, BenowitzN. Toxicologic causes of acute abdominal disorders. Emerg Med Clin North Am1989;7:667.

288. KirkebyO, RiseC. Intestinal ischemia after a single intravenous injection of deslanoside. Acta Chir Scand1984;150:91.

289. YoungG. Calcium channel blockers in emergency medicine. Ann Emerg Med1984;13:712. CrossRef

290. HallW, TalbertR, EreshefskyL. Cocaine abuse and its treatment. Pharmacotherapy1990;10:47.

291. YoungS, VosperH, PhillipsS. Cocaine: its effects on maternal and child health. Pharmacotherapy1992;12:2.

292. VanDetteJ, CornishL. Medical complications of illicit cocaine use. Clin Pharm1989;8:401.

293. MunizAE, EvansT. Acute gastrointestinal manifestations associated with use of crack. Am J Emerg Med2001;19:61. CrossRef

294. GourgoutisG, DasG. Gastrointestinal manifestations of cocaine addiction. Int J Clin Pharmacol Ther1994;32:136.

295. EllisCN, McAlexanderWW. Enterocolitis associated with cocaine use. Dis Colon Rectum2005;48:2313. CrossRef

296. HonD, SalloumL, HardyHWI, et al.Crack‐induced enteric ischemia. N J Med1990;87:1001.

297. GarfiaA, ValverdeJ, BorondoJ, et al.Vascular lesions in intestinal ischemia induced by cocaine‐alcohol abuse: report of a fatal case due to overdose. J Forensic Sci1990;35:740. CrossRef

298. SudhakarC, Al‐HakeemM, MacArthurJ, et al.Mesenteric ischemia secondary to cocaine abuse: case reports and literature review. Am J Gastroenterol1997;92:1053.

299. BrownD, RosenholtzM, MarshallJ. Ischemic colitis related to cocaine abuse. Am J Gastroenterol1994;89:1558.

300. BoutrosH, PautlerS, ChakrabartiS. Cocaine‐induced ischemic colitis with small‐vessel thrombosis of colon and gallbladder. J Clin Gastroenterol1997;24:49. CrossRef

301. MyersS, ClagettG, ValentineR, et al.Chronic intestinal ischemia caused by intravenous cocaine use: report of two cases and review of the literature. J Vasc Surg1996;23:724. CrossRef

302. WattooMA, OsundekoO. Cocaine‐induced intestinal ischemia. West J Med1999;170:47.

303. CaruanaD, WeinbachB, GoergJ, et al.Cocaine‐packet ingestion: diagnosis, management and natural history. Ann Intern Med1984;100:73. CrossRef

304. SuarezC, ArangoA, LesterJ. Cocaine‐condom ingestion. JAMA1977;238:1391. CrossRef

305. IntronaFJ, SmialekJ. The "mini‐packer" syndrome: fatal ingestion of drug containers in Baltimore, Maryland. Am J Forensic Med Pathol1989;10:21. CrossRef

306. BeermanR, NunezD, WetliC. Radiographic evaluation of the cocaine smuggler. Gastrointest Radiol1986;11:351. CrossRef

307. LeeK, KoehnM, RastegarRF, et al.Body packers: the ins and outs of imaging. Can Assoc Radiol J2012;63:318. CrossRef

308. TraubSJ, HoffmanRS, NelsonLS. Body packing–the internal concealment of illicit drugs. N Engl J Med2003;349:2519. CrossRef

309. Tfelt‐HansenP, SaxenaPR, DahlofC, et al.Ergotamine in the acute treatment of migraine: a review and European consensus. Brain2000;123:9. CrossRef

310. RogersDA, MansbergerJA. Gastrointestinal vascular ischemia caused by ergotamine. South Med J1989;82:1058. CrossRef

311. DeanaD, DeanP. Reversible ischemic colitis in young women: association with oral contraceptive use. Am J Surg Pathol1995;19:454. CrossRef

312. BrennanM, ClarkeA, MacbethA. Infarction of the midgut associated with oral contraceptives. N Engl J Med1968;279:1213. CrossRef

313. NothmannB, ChittinandS, SchusterM. Reversible mesenteric vascular occlusion associated with oral contraceptives. Am J Dig Dis1973;18:361. CrossRef

314. LamyA, RoyP, MorissetteJ, et al.Intimal hyperplasia and thrombosis of the visceral arteries in a young woman: possible relation with oral contraceptives and smoking. Surgery1988;103:706.

315. SchneidermanD, CelloJ. Intestinal ischemia and infarction associated with oral contraceptives. West J Med1986;145:350.

316. GreigJ. Oral contraceptives and intestinal ischemia. J R Coll Gen Pract1989;39:76.

317. MaungR, KellyJ, SchneiderM, et al.Mesenteric venous thrombosis due to antithrombin III deficiency. Arch Pathol Lab Med1988;112:37.

318. NaraynsinghV, RajuG, BusbyG. Mesenteric venous thrombosis and oral contraceptive use. Trop Geogr Med1985;37:192.

319. GraubardZ, FriedmanM. Mesenteric venous thrombosis associated with pregnancy and oral contraception. S Afr Med J1987;71:453.

320. BaileyKA, BassJ, NizalikE, et al.Unusual case of mesenteric venous thrombosis associated with oral contraceptive use in an adolescent girl. Pediatr Dev Pathol2005;8:128. CrossRef

321. HaramburuF. Hormonal contraceptives. In: DukesMNG(ed). Meyler's Side Effects of Drugs: an Encyclopedia of Adverse Reactions and Interactions, 12th edn. Amsterdam: Elsevier; 1992: 995.

322. KayC. Progestogens and arterial disease: evidence from the Royal College of General Practitioners study. Am J Obstet Gynecol1982;142:762.

323. PorterJ, HunterJ, DanielsonS, et al.Oral contraceptives and nonfatal vascular disease: recent experience. Obstet Gynecol1982;59:299.

324. GelfaudM. Ischemic colitis associated with a depot synthetic progesterone. Am J Dig Dis1972;17:275. CrossRef

325. GuedonC, BrunaT, DucrotteP, et al.Altered small bowel motility in severe chronic diarrhea with ticlopidine. Gastroenterol Clin Biol1989;13:934.

326. ChasanyO, BacqY, MetmanE, et al.Chronic severe diarrhea in the course of ticlopidine treatment. Gastroenterol Clin Biol1989;11:950.

327. JickH, PorterJ. Unwanted effects of drugs: drug‐induced gastrointestinal bleeding. Lancet1978;2:87. CrossRef

328. WiotJ, WeinsteinA, FelsonB. Duodenal hematoma induced by coumarin. AJR Am J Roentgenol1961;86:70.

329. EilandM, HanS, HicksG. Intramural hemorrhage of the small intestine. JAMA1978;239:139. CrossRef

330. FreearkR, CorleyR, NorcrossW, et al.Intramural hematoma of the duodenum. Arch Surg1966;92:463. CrossRef

331. JaffinB, BlissC, LamontJ. Significance of occult gastrointestinal bleeding during anticoagulation therapy. Am J Med1987;83:269. CrossRef

332. GurwitzJ, GoldbergR, HoldenA, et al.Age‐related risks of long‐term oral anticoagulant therapy. Arch Intern Med1988;148:1733. CrossRef

333. HughesC, ConnJJ, ShermanJ. Intramural hematoma of the gastrointestinal tract. Am J Surg1977;133:276. CrossRef

334. ShawPH, RanganathanS, GainesB. A spontaneous intramural hematoma of the bowel presenting as obstruction in a child receiving low‐molecular‐weight heparin. J Pediatr Hematol Oncol2005;27:558. CrossRef

335. AbbasMA, CollinsJM, OldenKW. Spontaneous intramural small‐bowel hematoma: imaging findings and outcome. AJR Am J Roentgenol2002;179:1389. CrossRef

336. ManuN, MartinL. Warfarin‐induced small bowel obstruction. Clin Lab Haematol2005;27:350. CrossRef

337. ChengJ, VemulaN, GendlerS. Small bowel obstruction caused by intramural hemorrhage secondary to anticoagulant therapy. Acta Gastroenterol Belg2008;71:342.

338. BirnsM, KatonR, KellerF. Intramural hematoma of the small intestine presenting with major upper gastrointestinal hemorrhage. Gastroenterology1979;77:1094.

339. CocksJ. Anticoagulants and the acute abdomen. Med J Aust1970;1:1138.

340. ChauW, NaA, LohI, et al.Real‐time ultrasound diagnosis of intramural intestinal hematoma. J Clin Ultrasound1989;17:392. CrossRef

341. MannesP, DerriksR, MoensR, et al.Multidisciplinary curative treatment for disseminated carcinoma of the breast. Cancer Treat Rep1976;60:85.

342. SharmaA, JamalMM. Opioid induced bowel disease: a twenty‐first century physicians' dilemma. Considering pathophysiology and treatment strategies. Curr Gastroenterol Rep2013;15:334. CrossRef

343. BrockC, OlesenSS, OlesenAE, et al.Opioid‐induced bowel dysfunction: pathophysiology and management. Drugs2012;72:1847. CrossRef

344. CerdaJ. The narcotic bowel syndrome. J Clin Gastroenterol1989;11:132. CrossRef

345. DrossmanDA, MorrisCB, EdwardsH, et al.Diagnosis, characterization, and 3‐month outcome after detoxification of 39 patients with narcotic bowel syndrome. Am J Gastroenterol2012;107:1426. CrossRef

346. SandgrenJ, McPheeM, GreenbergerN. Narcotic bowel syndrome treated with clonidine: resolution of abdominal pain and intestinal pseudo‐obstruction. Ann Intern Med1984;101:331. CrossRef

347. WongV, SobalaG, LosowskyM. A case of narcotic bowel syndrome successfully treated with clonidine. Postgrad Med J1994;70:138. CrossRef

348. TamayoAC, Diaz‐ZuluagaPA. Management of opioid‐induced bowel dysfunction in cancer patients. Support Care Cancer2004;12:613.

349. BrueraE, BrenneisC, MichaudM, et al.Continuous subcutaneous infusion of metoclopramide for treatment of narcotic bowel syndrome. Cancer Treat Rep1987;71:1211.

350. RoeD. Drug effects on nutrient absorption transport and metabolism. Drug Nutr Interact1985;4:117.

351. ChassanyO, MichauxA, BergmannJF. Drug‐induced diarrhoea. Drug Saf2000;22:53. CrossRef

352. ReadN. Speculations on the role of motility in the pathogenesis and treatment of diarrhea. Scand J Gastroenterol1983;18:45.

353. RaceT, PaesI, FaloonW. Intestinal malabsorption induced by oral colchicine: comparison with neomycin and cathartic agents. Am J Med Sci1970;259:32. CrossRef

354. DobbinsW, HerreroB, MansbackC. Morphologic alterations associated with neomycin‐induced malabsorption. Am J Med Sci1968;255:63. CrossRef

355. ReinerE, PattersonM. The effect of neomycin on disaccharidase activity of the small bowel. Clin Res1966;14:49.

356. SchneersonJ, GazzardB. Reversible malabsorption syndrome caused by methyldopa. BMJ1977;2:1456. CrossRef

357. ChenB, ShapiraJ, RavidM, et al.Steatorrhoea induced by allopurinol. BMJ1982;284:1914. CrossRef

358. IsaacsP, SladenG, FilipeI. Mefenamic acid enteropathy. J Clin Pathol1987;40:1221. CrossRef

359. PalvaI, HeinivaaraO, MattilaM. Drug‐induced malabsorption of vitamin B12 III: interference of PAS and folic acid in the absorption of vitamin B12. Scand J Haematol1966;3:149. CrossRef

360. ZieglerTR, Fernandez‐EstivarizC, GuLH, et al.Severe villus atrophy and chronic malabsorption induced by azathioprine. Gastroenterology2003;124:1950. CrossRef

361. DuclouxD, OttignonY, Semhoun‐DuclouxS, et al.Mycophenolate mofetil‐induced villous atrophy. Transplantation1998;66:1115. CrossRef

362. KamarN, FaureP, DupuisE, et al.Villous atrophy induced by mycophenolate mofetil in renal‐transplant patients. Transpl Int2004;17:463. CrossRef

363. LiapisG, BoletisJ, SkaliotiC, et al.Histological spectrum of mycophenolate mofetil‐related colitis: association with apoptosis. Histopathology2013;63:649.

364. ParfittJR, JayakumarS, DrimanDK. Mycophenolate mofetil‐related gastrointestinal mucosal injury: variable injury patterns, including graft‐versus‐host disease‐like changes. Am J Surg Pathol2008;32:1367. CrossRef

365. Rubio‐TapiaA, HermanML, LudvigssonJF, et al.Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc2012;87:732. CrossRef

366. StanichPP, YearsleyM, MeyerMM. Olmesartan‐associated sprue‐like enteropathy. J Clin Gastroenterol2013;47:894. CrossRef

367. TheophileH, DavidXR, Miremont‐SalameG, et al.Five cases of sprue‐like enteropathy in patients treated by olmesartan. Dig Liver Dis2014;46:465. CrossRef

368. VenencieP, CortezA, OrieuxG, et al.Clofazimine enteropathy. J Am Acad Dermatol1986;15:290. CrossRef

369. WasserbergerJ. AIDS drugs. In: EllenhornMJ, SchonwaldS, OrdogG(ed). Ellenhorn's Medical Toxicology, 2nd edn. Baltimore: Williams & Wilkins; 1997: 250.

370. RiddellR. The gastrointestinal tract. In: RiddellRH(ed). Pathology of Drug Induced and Toxic Disease. New York: Churchill Livingstone; 1982: 515.

371. AbigergesD, ChabotGG, ArmandJP, et al.Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. J Clin Oncol1995;13:210.

372. SalibaF, HagipantelliR, MissetJL, et al.Pathophysiology and therapy of irinotecan‐induced delayed‐onset diarrhea in patients with advanced colorectal cancer: a prospective assessment. J Clin Oncol1998;16:2745.

373. SandmeierD, ChaubertP, BouzoureneH. Irinotecan‐induced colitis. Int J Surg Pathol2005;13:215. CrossRef

374. SlavinR, DiasM, SaralR. Cytosine arabinoside‐induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical pathological study of 33 patients. Cancer1978;42:1747. CrossRef

375. RahmanR, BernsteinZ, VaickusL, et al.Unusual gastrointestinal complications of interleukin‐2 therapy. Immunotherapy1991;10:221. CrossRef

376. HalldorssonA, HunterG, ZukoskiC, et al.The possible role of cyclosporine in nonocclusive mesenteric ischemia in a renal transplant patient. Transplantation1991;51:1298.

377. HertzbergJ. Jejunitis acuta. Acta Chir Scand Suppl1954;194:150.

378. MurrellT, RothL, EgertonJ. Pig‐bel: enteritis necroticans: a study in diagnosis and management. Lancet1966;1:217. CrossRef

379. DavisM. A review of pigbel (necrotising enteritis) in Papua New Guinea, 1961–1984. P N G Med J1985;28:75.

380. MurrellT, WalkerP. The pigbel story of Papua New Guinea. Trans R Soc Trop Med Hyg1991;85:119. CrossRef

381. JohnsonS, EcheverriaP, TaylorD, et al.Enteritis necroticans among Khmer children at an evacuation site in Thailand. Lancet1987;2:496. CrossRef

382. LawrenceG, LehmannD, AnianG, et al.Impact of active immunisation against enteritis necroticans in Papua New Guinea. Lancet1990;336:1165. CrossRef

383. FarrantJ, TraillZ, ConlonC, et al.Pigbel‐like syndrome in a vegetarian in Oxford. Gut1996;39:336. CrossRef

384. WatsonD, AndrewJ, BantingS, et al.Pig‐bel but no pig: enteritis necroticans acquired in Australia. Med J Aust1991;155:47.

385. ClarkeL, Diekmann‐GuiroyB, McNameeW, et al.Enteritis necroticans with midgut necrosis caused by Clostridium perfringens. Arch Surg1994;129:557. CrossRef

386. PetrilloT, Beck‐SagueC, SongerJ, et al.Enteritis necroticans (pigbel) in a diabetic child. N Engl J Med2000;342:1250. CrossRef

387. SobelJ, MixterCG, KolheP, et al.Necrotizing enterocolitis associated with Clostridium perfringens type A in previously healthy North American adults. J Am Coll Surg2005;201:48. CrossRef

388. ZeisslerJ, Rassfeld‐SternbergL. Enteritis necroticans due to Clostridium welchii type, F. BMJ1949;1:267. CrossRef

389. OakleyC. The toxins of Cl. welchii type F. BMJ1949;1:269. CrossRef

390. HainE. Origin of Cl. welchii type F infection. BMJ1949;1:271.

391. HainE. On the occurrence of Cl. welchii type F in normal stool. BMJ1949;1:271.

392. MaM, LiJ, McClaneBA. Genotypic and phenotypic characterization of Clostridium perfringens isolates from Darmbrand cases in post‐World War II Germany. Infect Immun2012;80:4354. CrossRef

393. FieldHI, GoodwinRF. The experimental reproduction of enterotoxemia in piglets. J Hyg (Lond)1959;57:81. CrossRef

394. BullenJ, ScarisbrickR. Enterotoxemia of sheep: experimental reproduction of the disease. J Pathol Bacteriol1957;73:495. CrossRef

395. Van LoonF, Van SchaikS, BanikA, et al.Clostridium perfringens type C in bloody and watery diarrhea in Bangladesh. Trop Geogr Med1990;42:123.

396. SinghG, NarangV, MalikA, et al.Segmental enteritis: "enteritis necroticans" A clinicopathologic study. J Clin Gastroenterol1996;22:6. CrossRef

397. HagiyaH, NaitoH, SugiyamaJ, et al.Necrotizing duodenitis caused by Clostridium perfringens type A in a Japanese young man. Intern Med2012;51:2973. CrossRef

398. LundT, De BuyserM‐L, GranumP. A new cytotoxin from Bacillus cereus that may cause necrotic enteritis. Mol Microbiol2000;38:254. CrossRef

399. KliegmanR. Neonatal necrotizing enterocolitis. In: WyllieR, HyamsJS(ed). Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. Philadelphia: WB Saunders; 1999: 788.

400. IsraelE. Necrotizing enterocolitis. In: WalkerWA, HamiltonJR, WatkinsJB, et al. (ed). Pediatric Gastrointestinal Disease, 3rd edn. Philadelphia: BCDecker; 2000: 750.

401. NeuJ, WeissM. Necrotizing enterocolitis: pathophysiology and prevention. JPEN J Parenter Enteral Nutr1999;23(Suppl):S13. CrossRef

402. ClaudE, WalkerA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J2001;15:1398. CrossRef

403. NowickiPT. Ischemia and necrotizing enterocolitis: where, when, and how. Semin Pediatr Surg2005;14:152. CrossRef

404. NeuJ, ChenM, BeierleE. Intestinal innate immunity: how does it relate to the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg2005;14:137. CrossRef

405. HenryMC, MossRL. Current issues in the management of necrotizing enterocolitis. Semin Perinatol2004;28:221. CrossRef

406. Maayan‐MetzgerA, ItzchakA, MazkerethR, et al.Necrotizing enterocolitis in full‐term infants: case‐control study and review of the literature. J Perinatol2004;24:494. CrossRef

407. ReberKM, NankervisCA. Necrotizing enterocolitis: preventative strategies. Clin Perinatol2004;31:157. CrossRef

408. LeeJS, PolinRA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol2003;8:449. CrossRef

409. IbenS, RodriguezR. Neonatal necrotizing enterocolitis. In: WyllieR, HyamsJS, KayM(eds). Pediatric Gastrointestinal and Liver Disease. Philadelphia: Elsevier Saunders; 2011: 512. CrossRef

410. LinPW, NasrTR, StollBJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol2008;32:70. CrossRef

411. SylvesterK, LiuG, AlbaneseC. Necrotizing enterocolitis. In: CoranA, AdzickNS, KrummelTM, (eds). Pediatric Surgery, 7th edn. Philadelphia: Elsevier; 2012: 1187. CrossRef

412. SharmaR, HudakML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol2013;40:27. CrossRef

413. LuP, SodhiCP, JiaH, et al.Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol2014;306:G917. CrossRef

414. KosloskeA. A unifying hypothesis for pathogenesis and prevention of necrotizing enterocolitis. J Pediatr1990;117(Suppl):68. CrossRef

415. NeuJ. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am1996;43:409. CrossRef

416. RayvisS, AmbalavananN, WrightL, et al.Randomized trial of slow versus fast feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr1999;134:293. CrossRef

417. KennedyK, TysonJ, ChamnanvanakijS. Rapid versus slow rate of advancement of feedings for promoting growth and preventing necrotizing enterocolitis in parenterally fed low‐birth‐weight infants (Cochrane review) The Cochrane Library, Oxford: Update Software, 2001(3).

418. SpritzerR, KoolenA, BaertsW, et al.A prolonged decline in the incidence of necrotizing enterocolitis after the introduction of a cautious feeding regimen. Acta Paediatr Scand1988;77:909. CrossRef

419. ZabielskiP, Groh‐WargoS, MooreJ. Necrotizing enterocolitis: feeding in endemic and epidemic periods. JPEN J Parenter Enteral Nutr1989;13:520. CrossRef

420. AndersonD, KliegmanR. The relationship of neonatal alimentation practices to the occurrence of endemic necrotizing enterocolitis. Am J Perinatol1991;8:62. CrossRef

421. McKeownR, MarshD, AmarnathU, et al.Role of delayed feeding and of feeding increments in necrotizing enterocolitis. J Pediatr1992;121:764. CrossRef

422. Bin‐NunA, BromikerR, WilschanskiM, et al.Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr2005;147:192. CrossRef

423. LinHC, SuBH, ChenAC, et al.Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics2005;115:1.

424. PatelRM, DenningPW. Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?Clin Perinatol2013;40:11. CrossRef

425. ChenCC, Allan WalkerW. Probiotics and the mechanism of necrotizing enterocolitis. Semin Pediatr Surg2013;22:94. CrossRef

426. BernardoWM, AiresFT, CarneiroRM, et al.Effectiveness of probiotics in the prophylaxis of necrotizing enterocolitis in preterm neonates: a systematic review and meta‐analysis. J Pediatr (Rio J)2013;89:18. CrossRef

427. TorrazzaRM, NeuJ. The altered gut microbiome and necrotizing enterocolitis. Clin Perinatol2013;40:93. CrossRef

428. GrishinA, PapillonS, BellB, et al.The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg2013;22:69. CrossRef

429. CarlisleEM, MorowitzMJ. The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr2013;25:382. CrossRef

430. JeffriesG, HolmanH, SleisengerM. Plasma proteins and the gastrointestinal tract. N Engl J Med1962;266:652. CrossRef

431. WaldmannT, WochnerR, StroberW. The role of the gastrointestinal tract in plasma protein metabolism: studies with 51Cr‐albumin. Am J Med1986;46:275. CrossRef

432. GitlinD, KlinenbergJ, HughesW. Site of catabolism of serum albumin. Nature1958;181:1064. CrossRef

433. JeejeebhoyK, JarnumS, SinghB, et al.95Nb‐labelled albumin for the study of gastrointestinal albumin loss. Scand J Gastroenterol1968;3:449. CrossRef

434. KatzJ, RosenfeldS, SellersA. Sites of plasma albumin catabolism in the rat. Am J Physiol1961;200:1301.

435. Van TongerenJ, ReichertW. Demonstration of protein‐losing gastro‐enteropathy: the quantitative estimation of gastrointestinal protein, loss using 51Cr‐labelled plasma proteins. Clin Chim Acta1966;14:42. CrossRef

436. WaldmannT, WochnerR, StroberW. The role of the gastrointestinal tract in plasma protein metabolism: studies with 51Cr‐albumin. Am J Med1969;46:275. CrossRef

437. WochnerR, WeissmanS, WaldmanT, et al.Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss. J Clin Invest1968;47:3. CrossRef

438. SteinfeldJ, DavidsonJ, GordonR, et al.Mechanism of hypoproteinemia in patients with regional enteritis and ulcerative colitis. Am J Med1960;29:405. CrossRef

439. BeekenW, BuschH, SylwesterD. Intestinal protein loss in Crohn's disease. Gastroenterology1972;62:207.

440. CitrinY, SterlingK, HalstedJ. Mechanism of hypoproteinemia associated with giant hypertrophy of gastric mucosa. N Engl J Med1957;257:906. CrossRef

441. OverholtB, JeffriesG. Hypertrophic hypersecretory protein losing gastropathy. Gastroenterology1979;58:80.

442. WaldmannT, WochnerR, LasterL, et al.Allergic gastroenteropathy: a cause of excessive gastrointestinal protein loss. N Engl J Med1967;276:761. CrossRef

443. KleinN, HargroveR, SleisengerM, et al.Eosinophilic gastroenteritis. Medicine (Baltimore)1970;49:299. CrossRef

444. GordonR. Protein‐losing enteropathy in the sprue syndrome. Lancet1961;1:55. CrossRef

445. RubiniM, SheehyT, MeroneyW, et al.Exudative enteropathy: II Observations in tropical sprue. J Lab Clin Med1961;58:902.

446. StarkM, BattsK, AlexanderG. Protein‐losing enteropathy with collagenous colitis. Am J Gastroenterol1992;87:780.

447. MeuwissenS, RidwanB, HasperH, et al.Hypertrophic protein‐losing gastropathy: a retrospective analysis of 40 cases in The Netherlands: the Dutch Menetrier Study Group. Scand J Gastroenterol Suppl1992;194:1. CrossRef

448. Wing‐HarkinsD, DellingerG, LynchC, et al.Eosinophilic gastro‐enteritis associated with protein‐losing enteropathy and protein C deficiency. J Int Med Res1996;24:155.

449. IanniccilloH, VarskyC, RizzoloM, et al.Peutz‐Jeghers syndrome associated with adenocarcinoma and protein‐losing enteropathy. Gastrointest Endosc2000;52:573. CrossRef

450. FreezeH. Disorders in protein glycosylation and potential therapy: tip of an iceberg?J Pediatr1998;133:593. CrossRef

451. BennishM, SalemM, WahedM. Enteric protein loss during shigellosis. Am J Gastroenterol1993;88:53.

452. CooperstockM, RiegleL, FabacherD, et al.Relationship between fecal alpha 1‐antitrypsin and colonization with Clostridium difficile in asymptomatic infants. J Pediatr1985;107:257. CrossRef

453. RyboltA, BennettR, LaughonB, et al.Protein‐losing enteropathy associated with Clostridium difficile infection. Lancet1989;1:1353. CrossRef

454. DansingerML, JohnsonS, JansenPC, et al.Protein‐losing enteropathy is associated with Clostridium difficile diarrhea but not with asymptomatic colonization: a prospective, case‐control study. Clin Infect Dis1996;22:932. CrossRef

455. SullivanP, LunnP, Northrop‐ClewesC, et al.Parasitic infection of the gut and protein‐losing enteropathy. J Pediatr Gastroenterol Nutr1992;15:404. CrossRef

456. KiireC, GwavavaN. Protein losing enteropathy: an unusual presentation of intestinal schistosomiasis. Gut1987;28:616. CrossRef

457. El AgganH, MarzoukS. Fecal alpha‐1‐antitrypsin concentration in patients with schistosomal hepatic fibrosis. J Egypt Soc Parasitol1992;22:195.

458. ShermanP, LiebmanW. Apparent protein‐losing enteropathy associated with giardiasis. Am J Dis Child1980;134:893.

459. SuttonD, KamathK. Giardiasis with protein‐losing enteropathy. J Pediatr Gastroenterol Nutr1985;4:56. CrossRef

460. KormanS, Bar‐OzB, MandelbergA, et al.Giardiasis with protein‐losing enteropathy: diagnosis by fecal alpha‐1‐antritrypsin determination. J Pediatr Gastroenterol Nutr1990;10:249. CrossRef

461. SchreiberD, BlacklowN, TrierJ. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med1973;288:1318. CrossRef

462. DossetorJ, WhittleH. Protein‐losing enteropathy and malabsorption in acute measles enteritis. BMJ1975;2:592. CrossRef

463. SarkerS, WahadM, RahamanM, et al.Persistent protein losing enteropathy in post measles diarrhoea. Arch Dis Child1986;61:739. CrossRef

464. BelamarichP, OrtizA, MonesR. Severe hypoproteinemia and edema in association with varicella infection. Clin Pediatr (Phila)1991;30:56. CrossRef

465. NakaseH, ItaniT, MimuraJ, et al.Transient protein‐losing enteropathy associated with cytomegalovirus infection in a noncompromised host: a case report. Am J Gastroenterol1998;93:1005. CrossRef

466. SuJ, SmithM, RerknimitrR, et al.Small intestine bacterial overgrowth presenting as protein‐losing enteropathy. Dig Dis Sci1998;43:679. CrossRef

467. YaziciY, ErkanD, LevineDM, et al.Protein‐losing enteropathy in systemic lupus erythematosus: report of a severe, persistent case and review of pathophysiology. Lupus2002;11:119. CrossRef

468. OssandonA, BombardieriM, CoariG, et al.Protein losing enteropathy in systemic lupus erythematosus: role of diet and octreotide. Lupus2002;11:465. CrossRef

469. WoodM, FouldsI, FrenchM. Protein losing enteropathy due to systemic lupus erythematosus. Gut1984;25:1013. CrossRef

470. EdmundsS, GanjuV, BeveridgeB, et al.Protein‐losing enteropathy in systemic lupus erythematosus. Aust N Z J Med1988;18:868. CrossRef

471. BennerK, MontanaroA. Protein‐losing enteropathy in systemic lupus erythematosus: diagnosis and monitoring immunosuppressive therapy by alpha‐1‐antitrypsin clearance in the stool. Dig Dis Sci1989;34:132. CrossRef

472. KobayashiK, AsakuraH, YoshidaS, et al.Protein‐losing enteropathy in systemic lupus erythematosus: observations by magnifying endoscopy. Dig Dis Sci1989;34:1924. CrossRef

473. HizawaK, IidaM, AoyagiK, et al.Double‐contrast radiographic assessment of lupus‐associated enteropathy. Clin Radiol1998;53:825. CrossRef

474. YoshidaM, MiyataM, SakaM, et al.Protein‐losing enteropathy exacerbated with the appearance of symptoms of systemic lupus erythematosus. Intern Med2001;40:449. CrossRef

475. EbertEC, HagspielKD. Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol2011;45:436. CrossRef

476. LawST, MaKM, LiKK. The clinical characteristics of lupus related protein‐losing enteropathy in Hong Kong Chinese population: 10 years of experience from a regional hospital. Lupus2012;21:840. CrossRef

477. TianXP, ZhangX. Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol2010;16:2971. CrossRef

478. ZhengWJ, TianXP, LiL, et al.Protein‐losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients. J Clin Rheumatol2007;13:313. CrossRef

479. PeredniaD, CuroshN. Lupus‐associated protein‐losing enteropathy. Arch Intern Med1990;150:1806. CrossRef

480. TerrenP. Protein‐losing enteropathy and mixed connective‐tissue disease. Med J Aust1988;149:558.

481. FuruyaT, SuzukiT, OnodaN, et al.Mixed connective tissue disease associated with protein losing enteropathy: successful treatment with intravenous cyclophosphamide therapy. Intern Med1992;31:1359. CrossRef

482. KanoK, OzawaT, KuwashimaS, et al.Uncommon multisystemic involvement in a case of Henoch‐Schonlein purpura. Acta Paediatr Jpn1998;40:159. CrossRef

483. TsutsumiA, SugiyamaT, MatsumuraR, et al.Protein losing enteropathy associated with collagen vascular diseases. Ann Rheum Dis1991;50:178. CrossRef

484. SuzukiC, HigakiS, NishiakiM, et al.99mTc‐HSA‐D scintigraphy in the diagnosis of protein‐losing gastroenteropathy due to secondary amyloidosis. J Gastroenterol1997;32:78. CrossRef

485. KawaguchiM, KoizumiF, ShimaoM, et al.Protein‐losing enteropathy due to secondary amyloidosis of the gastrointestinal tract. Acta Pathol Jpn1993;43:333.

486. TatemichiM, NagataH, MorinagaS, et al.Protein‐losing enteropathy caused by mesenteric vascular involvement of neurofibromatosis. Dig Dis Sci1993;38:1549. CrossRef

487. HonboK, KawajiH, TsuchimochiM, et al.Protein‐losing enteropathy due to thrombophlebitis of the mesenteric vein: report of a case. Surg Today1998;28:932. CrossRef

488. MistilisS, SkyringA, StephenD. Intestinal lymphangiectasia: mechanism of enteric loss of plasma protein and fat. Lancet1965;1:77. CrossRef

489. Van TillburgA, van BlankensteinM, VerschoorL. Intestinal lymphangiectasia in systemic sclerosis. Am J Gastroenterol1988;83:1418.

490. EdworthyS, FritzlerM, KellyJ, et al.Protein‐losing enteropathy in systemic lupus erythematosus associated with intestinal lymphangiectasia. Am J Gastroenterol1990;85:1398.

491. PopovicO, BrkicS, BojicP, et al.Sarcoidosis and protein losing enteropathy. Gastroenterology1980;78:119.

492. GodeauB, FarcetJ, DelchierJ, et al.Protein‐losing enteropathy in gastrointestinal sarcoidosis associated with malignant lymphoma. J Clin Gastroenterol1992;14:78. CrossRef

493. LasterL, WaldmannT, FensterL, et al.Reversible enteric protein loss in Whipple's disease. Gastroenterology1962;42:762.

494. SouthernJ, MoscickiR, MagroC, et al.Lymphedema. JAMA1989;261:1467. CrossRef

495. KonarA, BrownC, HancockB, et al.Protein losing enteropathy as a sole manifestation of non‐Hodgkins lymphoma. Postgrad Med1986;62:399. CrossRef

496. HenleyJ, KratzerS, SeoI, et al.Endometriosis of the small intestine presenting as a protein‐losing enteropathy. Am J Gastroenterol1993;88:130.

497. WellmanW, LuskaG, StenderH, et al.Reduced intestinal protein loss in Crohn's disease after lymphovenous anastomosis. Digestion1985;32:149. CrossRef

498. DavidsonJ, WaldmannR, GoodmanD, et al.Protein‐losing enteropathy in congestive heart failure. Lancet1961;1:899. CrossRef

499. WilkinsonP, PintoB, SeniorJ. Reversible protein‐losing enteropathy with intestinal lymphangiectasia secondary to chronic constrictive pericarditis. N Engl J Med1965;273:1178. CrossRef

500. CrossleyJR, ElliottRB. Simple method for diagnosing protein‐losing enteropathies. Br Med J1977;1:428. CrossRef

501. TakedaH, NishiseS, FurukawaM, et al.Fecal clearance of alpha1‐antitrypsin with lansoprazole can detect protein‐losing gastropathy. Dig Dis Sci1999;44:2313. CrossRef

502. FlorentC, VidonN, FlourieB, et al.Gastric clearance of alpha‐1‐antitrypsin under cimetidine perfusion. New test to detect protein‐losing gastropathy?Dig Dis Sci1986;31:12. CrossRef

503. FlorentC, L'HirondelC, DexmazuresC, et al.Intestinal clearance of alpha‐1‐antitrypsin: a sensitive method for the detection of protein‐losing enteropathy. Gastroenterology1981;81:777.

504. StryglerB, NicorM, SantangeloW, et al.Alpha‐1‐antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology1990;99:1380.

505. PerraultJ, MarkowitzH. Protein‐losing gastroenteropathy and the intestinal clearance of serum alpha‐1‐antitrypsin. Mayo Clin Proc1984;59:7278.

506. ThomasD, SinatraF, MerritR. Random fecal alpha‐1‐antitrypsin concentration in children with gastrointestinal disease. Gastroenterology1981;80:776.

507. ThomasD, SinatraF, MerritR. Fecal alpha‐1‐antitrypsin excretion in young people with Crohn's disease. J Pediatr Gastroenterol Nutr1983;2:491. CrossRef

508. MaguzzuG, JaconoG, Di PasqualeG, et al.Reliability and usefulness of random fecal alpha‐1‐antitrypsin concentration: further simplification of the method. J Pediatr Gastroenterol Nutr1985;4:402. CrossRef

509. DivgiC, LisannN, YehS, et al.Technetium‐99m albumin scintigraphy in the diagnosis of protein‐losing enteropathy. J Nucl Med1986;27:1710.

510. OommenR, KurienG, BalakrishnanN, et al.Tc‐99m albumin scintigraphy in the localization of protein loss in the gut. Clin Nucl Med1992;17:787. CrossRef

511. BhatnagarA, LahotiD, SinghA, et al.Scintigraphic diagnosis of protein losing enteropathy using Tc‐99m dextran. Clin Nucl Med1995;20:1070. CrossRef

512. BhatnagarA, SinghA, LahotiD, et al.Technetium‐99m dextran: a promising new protein‐losing enteropathy imaging agent. Eur J Nucl Med1996;23:575. CrossRef

513. ChiuN, LeeB, HwangS, et al.Protein‐losing enteropathy: diagnosis with (99m)Tc‐labeled human serum albumin scintigraphy. Radiology2001;219:86. CrossRef

514. KiratliP, ErbasB, OzenH, et al.Tc‐99m dextran scintigraphy in the diagnosis of protein losing enteropathy. Ann Nucl Med2001;15:153. CrossRef

515. ChauTN, MokMY, ChanEY, et al.Evaluation of performance of measurement of faecal alpha(1)‐antitrypsin clearance and technetium‐99m human serum albumin scintigraphy in protein‐losing enteropathy. Digestion2011;84:199. CrossRef

516. TakenakaH, OhmiyaN, HirookaY, et al.Endoscopic and imaging findings in protein‐losing enteropathy. J Clin Gastroenterol2012;46:575. CrossRef

517. GattornoM, BuoncompagniA, BarabinoA, et al.Severe hypoalbuminaemia in a systemic lupus erythematosus‐like patient. Eur J Pediatr2002;161:84. CrossRef

518. SunagawaT, KinjoF, GakiyaI, et al.Successful long‐term treatment with cyclosporin A in protein losing gastroenteropathy. Intern Med2004;43:397. CrossRef

519. MokCC, YingKY, MakA, et al.Outcome of protein‐losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine. Rheumatology (Oxford)2006;45:425. CrossRef

520. FushimiT, TakahashiY, KashimaY, et al.Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid2005;12:48. CrossRef

521. BayerdorfferE, RitterM, HatzR, et al.Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori: is Helicobacter pylori a pathogenic factor in Menetrier's disease?Gut1994;35:701. CrossRef

522. YeatonP, FriersonHJ. Octreotide reduces enteral protein losses in Menetrier's disease. Am J Gastroenterol1993;88:95.

523. JeffriesG, ChapmanA, SleisengerM. Low‐fat diet in intestinal lymphangiectasia: its effect on albumin metabolism. N Engl J Med1964;270:761. CrossRef

524. TiftW, LloydJ. Intestinal lymphangiectasia: long term results with MCT diet. Arch Dis Child1975;50:269. CrossRef

525. MistilisS, SkyringA. Intestinal lymphangiectasia: therapeutic effect of lymph venous anastomosis. Am J Med1966;40:634. CrossRef

526. UmarSB, DiBaiseJK. Protein‐losing enteropathy: case illustrations and clinical review. Am J Gastroenterol2010;105:43. CrossRef

527. PringotJ, BodartP. Inflammatory diseases. In: MargulisAR, BurhenneHJ(eds). Alimentary Tract Radiology. St. Louis, MO: CV Mosby; 1989: 804.